Trials / Completed
CompletedNCT01431235
CBT for Patients With Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorders
Investigating the Efficacy of Cognitive Behavioral Therapy in Patients With Substance Use Disorder and Comorbid ADHD. A Randomized Controlled Trial With Cognitive Behavioral Therapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 184 (actual)
- Sponsor
- Arkin · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if cognitive behavioral therapy is effective in treating ADHD symptoms in patients with substance use disorders and comorbid ADHD.
Detailed description
Attention Deficit Hyperactivity Disorder(ADHD) is an important comorbid condition in patients with substance use disorders (SUD). The prevalence of ADHD in patients with SUD is estimated 23%, and ADHD is associated with an untoward prognosis of SUD. However, adequate treatment programs for patients with ADHD and SUD are not available. Results of medication trials for patients with ADHD and SUD are disappointing, and cognitive behavioral therapy (CBT) has not yet been investigated in this population. In patients with ADHD without comorbid SUD, the results of CBT in randomized trials are positive. The purpose of this study is to investigate if CBT is effective in treating ADHD symptoms in patients with ADHD and SUD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | cognitive behavioral therapy for treating ADHD symptoms | 5 sessions of one hour CBT for treating ADHD symptoms by a trained health care worker |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2011-09-09
- Last updated
- 2017-01-16
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT01431235. Inclusion in this directory is not an endorsement.